skin cancer

The Spring Swing® Sun Safety Tour is a partnership between Moffitt and the Tampa Bay Rays offering free skin cancer screenings at specified baseball spring training venues throughout Florida. Screeners look for early signs of skin cancer and promote sun safety with help from Moffitt’s Mole Patrol® team. Free giveaways include Blue Lizard sunscreen,Continue Reading

Patients with advanced melanoma who develop metastases in the leptomeninges, the fluid filled membranes surrounding the brain and spinal cord, have an extremely dismal prognosis. Most patients only survive for 8 to 10 weeks after diagnosis. One reason for this poor prognosis is that very little information is known aboutContinue Reading

This week, the Board of Directors of Moffitt Cancer Center accepted the resignation of its president and CEO, Dr. Alan List, and the center director, Thomas Sellers, for violations of conflict of interest rules through their work in China.  Moffitt initiated an internal review of team members’ collaborations with researchContinue Reading

Two students from Tampa were recently honored for their innovations at the Florida Invention Convention.  Makana Salim-Uesi, a 7th grade student at Williams Middle Magnet School, took 1st Place in the competition. Her invention, “RCV H20″. is a model of a labor-saving device that can transport and filter water atContinue Reading

Drug therapies that target a specific molecule have changed the way patients are treated for cancer and greatly improved survival rates. However, some patients do not respond to these therapies because the drug is not reaching the tumor cells effectively. In a new study published in Scientific Reports, Moffitt Cancer CenterContinue Reading

Moffitt Cancer Center has been named one of the 2018 Top 10 Nonprofit Companies for Executive Women by the National Association for Female Executives (NAFE). The recognition spotlights organizations that identify and advance women through their ranks. The announcement will be featured in the April/May issue of Working Mother and on workingmother.com. “We areContinue Reading

Behind a message of “Fight with Courage,” Tampa resident Valarie Schlosser will be one of the 25 people featured in a new PSA rotating in Times Square this March for Colorectal Cancer Awareness Month. Schlosser was diagnosed with colorectal cancer at 49 and has become an ambassador for the country’sContinue Reading

Stem cell transplants can cure patients with high-risk leukemia or lymphoma.  Graft-versus-host disease (GVHD) is a potentially life-threatening side effect that occurs when the donor’s immune cells attack the recipient’s normal tissues. Moffitt Cancer Center researchers are trying to identify new drug targets to reduce the risk of GVHD. Their new study, publishedContinue Reading

It’s known as a date which will live in infamy, and for 96-year-old George Kondas, the attack on Pearl Harbor seems like it was yesterday. He’ll never forget the sight of hundreds of planes coming in from every direction, ships burning, the sinking of the Arizona, the Oklahoma turning overContinue Reading

The U.S. News & World Report’s Best Hospitals for Cancer rankings were released Tuesday and it was amazing news for the Moffitt Cancer Center, now ranked at number six on the list, rising from number 18 in 2015, making the facility the top ranked cancer hospital in the Southeast and in the state ofContinue Reading

The use of electronic cigarettes (“e-cigarettes”) has increased dramatically in recent years.  The majority of new “vapers” were already cigarette smokers. To date, little is known about how e-cigarette use changes over time or how it affects the use of traditional cigarettes.  Such information would be valuable for understanding theContinue Reading

Moffitt Cancer Center will present results from a phase 1 study of selinexor in combination with liposomal doxorubicin and dexamethasone in patients with relapsed and refractory multiple myeloma. The findings will be discussed Monday, June 6, during the American Society of Clinical Oncology Annual Meeting in Chicago. Selinexor is theContinue Reading

Radiation is a commonly used therapeutic option to treat liver metastases, with the majority of tumors maintained under control after one year. However, some patients do not respond as well to radiation treatment, and the factors that predict patient outcomes are unclear. Moffitt Cancer Center researchers report that liver metastases haveContinue Reading